On the Medtech POV podcast , AdvaMed® President and CEO Scott Whitaker sat down with Jacob “Jake” Leach, Executive Vice President and Chief Operating Officer at Dexcom, to discuss the…
On the Medtech POV podcast, AdvaMed® President and CEO Scott Whitaker sat down with Martina Navratilova and Chris Evert, professional tennis legends who met as teen-age competitors and whose friendship…
AdvaMed, The Medtech Association®, commended the House of Representatives’ bipartisan Task Force on Artificial Intelligence for urging the Centers for Medicare & Medicaid Services (CMS) to develop a formalized payment…
AdvaMed, The Medtech Association®, asked the United States Court of Appeals to support a fair and balanced approach to patent damages.
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Martin Makary to Lead FDA:
AdvaMed, The Medtech Association®, recently published a technical white paper outlining concerns with third-party modification of interventional X-ray equipment, which can pose unforeseen risks for patients and providers.
AdvaMed®, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient…
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Mehmet Oz to serve as Administrator…
AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker on President-elect Trump’s intention to nominate Robert F. Kennedy, Jr., to serve as Secretary of…
AdvaMed, The Medtech Association®, released the following statement on the 2024 election from President and CEO Scott Whitaker: